Can we Use a Simple Blood Test to Reduce Unnecessary Adverse Effects From Radiotherapy by Timely Identification of Radiotherapy-resistant Rectal Cancers? MeD-Seq Rectal Study
Condition: Pathological Response Rate, Circulating Tumour DNA Intervention: Diagnostic Test: MeD-seq Sponsor: Erasmus Medical Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials